The various readouts presented here will enable the model to be used for drug discovery, putative gene therapies, or testing of new therapeutic modalities to ameliorate disease in patients suffering from not just SPG47, but for all AP-4 deficiency diseases linked by their shared pathological phenotypes. The gene discussed is AP4B1; the disease is hyperinsulinemic hypoglycemia, familial, 4.